论文部分内容阅读
1有效成份莫西赛利盐酸盐（moxisylytehydrochloride）2剂型冻干粉末制剂3开发与上市厂商（法）Fbdrier公司，1996年在法国上市，1四7年11月在英国上市。4作用特点治疗勃起功能障碍。使用后阴茎异常勃起的危险性极小。5临床评价据估计，由于勃起功能障碍导致不能性交的男性占10
1 active ingredient moxisylyte hydrochloride 2 Formulation lyophilized powder formulation 3 Developed and marketed by Fbdrier, a French company listed in France in 1996 and listed in the United Kingdom in November 1977. 4 Features of the treatment of erectile dysfunction. After use, the risk of abnormal erection penis is minimal. 5 Clinical Evaluation It is estimated that 10% of men can not have intercourse due to erectile dysfunction